Business

Algorae cardiovascular drug betters beta-blockers in studies

Algorae Pharmaceuticals says its new AI-168 drug candidate shows early potential to improve on treatments to protect the heart from cardiovascular stressors.

Business / Companies

Brisbane Times – Business

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Business